carbimazole has been researched along with Pseudomonas Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lynch, MJ; Woodford, NW | 1 |
| Bernard, E; Brucker, F; Chichmanian, RM; Cua, E; del Giudice, P; Dellamonica, P; Oregionni, O | 1 |
2 other study(ies) available for carbimazole and Pseudomonas Infections
| Article | Year |
|---|---|
Fatality complicating agranulocytosis in the setting of carbimazole therapy.
Topics: Agranulocytosis; Antithyroid Agents; Carbimazole; Fatal Outcome; Female; Forensic Pathology; Graves Disease; Humans; Middle Aged; Pancytopenia; Pseudomonas Infections; Sepsis | 2008 |
Pseudomonas aeruginosa ecthyma gangrenosum and facial cellulitis complicating carbimazole-induced agranulocytosis.
Topics: Adult; Agranulocytosis; Antithyroid Agents; Carbimazole; Cellulitis; Diagnosis, Differential; Ecthyma; Face; Female; Graves Disease; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2006 |